Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

A systematic review of the voice-tagging hypothesis of speech-in-noise perception.

Rosenthal MA.

Neuropsychologia. 2019 Nov 9;136:107256. doi: 10.1016/j.neuropsychologia.2019.107256. [Epub ahead of print] Review.

PMID:
31715197
2.

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial.

Olafson LR, Siddell AH, Field KM, Byrnes M, Rapkins RW, Ng B, Nixdorf S, Barnes EH, Johns TG, Yip S, Simes J, Nowak AK, Rosenthal MA, McDonald KL.

J Clin Neurosci. 2019 Dec;70:157-163. doi: 10.1016/j.jocn.2019.08.044. Epub 2019 Sep 30.

PMID:
31582283
3.

A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer.

Lok SW, Whittle JR, Vaillant F, Teh CE, Lo LL, Policheni AN, Bergin ART, Desai J, Ftouni S, Gandolfo LC, Liew D, Liu HK, Mann GB, Moodie K, Murugasu A, Pal B, Roberts AW, Rosenthal MA, Shackleton K, Silva MJ, Siow ZR, Smyth GK, Taylor L, Travers A, Yeo B, Yeung MM, Bujak AZ, Dawson SJ, Gray DHD, Visvader JE, Lindeman GJ.

Cancer Discov. 2019 Mar;9(3):354-369. doi: 10.1158/2159-8290.CD-18-1151. Epub 2018 Dec 5.

PMID:
30518523
4.

Resuscitative Endovascular Balloon Occlusion of the Aorta: Implementation and Preliminary Results at an Academic Level I Trauma Center.

Darrabie MD, Croft CA, Brakenridge SC, Mohr AM, Rosenthal MA, Mercier NR, Moore FA, Smith RS.

J Am Coll Surg. 2018 Jul;227(1):127-133. doi: 10.1016/j.jamcollsurg.2018.03.042. Epub 2018 Apr 27.

PMID:
29709584
5.

The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection.

Muscat AM, Wong NC, Drummond KJ, Algar EM, Khasraw M, Verhaak R, Field K, Rosenthal MA, Ashley DM.

Oncotarget. 2017 Dec 15;9(8):7844-7858. doi: 10.18632/oncotarget.23541. eCollection 2018 Jan 30.

6.

Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial.

Field KM, Fitt G, Rosenthal MA, Simes J, Nowak AK, Barnes EH, Sawkins K, Goh C, Moffat BA, Salinas S, Cher L, Wheeler H, Hovey EJ, Phal PM; CABARET/COGNO Investigators.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e359-e365. doi: 10.1111/ajco.12806. Epub 2017 Nov 8.

PMID:
29114999
7.

Precision oncology using a clinician-directed, tailored approach to molecular profiling.

Lam M, Tran B, Beck S, Tie J, Herath D, Whittle J, Kwan EM, Fox SB, Fellowes A, Ananda S, Lipton L, Gibbs P, Rosenthal MA, Desai J.

Asia Pac J Clin Oncol. 2018 Feb;14(1):84-90. doi: 10.1111/ajco.12787. Epub 2017 Oct 30.

PMID:
29083093
8.

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial.

Hovey EJ, Field KM, Rosenthal MA, Barnes EH, Cher L, Nowak AK, Wheeler H, Sawkins K, Livingstone A, Phal P, Goh C, Simes J; CABARET/COGNO investigators.

Neurooncol Pract. 2017 Sep;4(3):171-181. doi: 10.1093/nop/npw025. Epub 2017 May 25.

9.

The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).

Field KM, Phal PM, Fitt G, Goh C, Nowak AK, Rosenthal MA, Simes J, Barnes EH, Sawkins K, Cher LM, Hovey EJ, Wheeler H.

Cancer. 2017 Sep 15;123(18):3576-3582. doi: 10.1002/cncr.30838. Epub 2017 Jul 5.

10.

Ferric citrate controls serum phosphorus in dialysis patients: retrospective data‚Ä©.

Hain DJ, Marinaro M, Koeper DW, Rosenthal MA, Chillemi S, Huffman JM, Gerbeling T, Pritsiolas JM, Loram LC, Pergola PE.

Clin Nephrol. 2017 Jul;88(1):12-18. doi: 10.5414/CN109057.

11.

Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma.

Field KM, King MT, Simes J, Espinoza D, Barnes EH, Sawkins K, Rosenthal MA, Cher L, Hovey E, Wheeler H, Nowak AK.

J Neurooncol. 2017 Jul;133(3):623-631. doi: 10.1007/s11060-017-2479-8. Epub 2017 May 22.

PMID:
28534153
12.

Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.

Bennett IE, Field KM, Hovens CM, Moffat BA, Rosenthal MA, Drummond K, Kaye AH, Morokoff AP.

J Neurooncol. 2017 Jan;131(2):321-329. doi: 10.1007/s11060-016-2300-0. Epub 2016 Nov 28.

PMID:
27896520
13.

Hemispheric asymmetry in the hierarchical perception of music and speech.

Rosenthal MA.

Psychol Bull. 2016 Nov;142(11):1165-1178. Epub 2016 Aug 25. Review.

PMID:
27559748
14.

Evolving management of low grade glioma: No consensus amongst treating clinicians.

Field KM, Rosenthal MA, Khasraw M, Sawkins K, Nowak AK.

J Clin Neurosci. 2016 Jan;23:81-87. doi: 10.1016/j.jocn.2015.05.038. Epub 2015 Oct 23.

PMID:
26601811
15.

Recurrent glioblastoma: Current patterns of care in an Australian population.

Parakh S, Thursfield V, Cher L, Dally M, Drummond K, Murphy M, Rosenthal MA, Gan HK.

J Clin Neurosci. 2016 Feb;24:78-82. doi: 10.1016/j.jocn.2015.08.025. Epub 2015 Nov 6.

PMID:
26549675
16.

First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma.

Whittle JR, Lickliter JD, Gan HK, Scott AM, Simes J, Solomon BJ, MacDiarmid JA, Brahmbhatt H, Rosenthal MA.

J Clin Neurosci. 2015 Dec;22(12):1889-94. doi: 10.1016/j.jocn.2015.06.005. Epub 2015 Aug 13.

PMID:
26279503
17.

Glioblastoma multiforme in the very elderly.

Connon FV, Rosenthal MA, Drummond K.

Neurosurg Rev. 2016 Jan;39(1):55-60; discussion 60-1. doi: 10.1007/s10143-015-0652-0. Epub 2015 Jul 26.

PMID:
26208944
18.

Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.

Field KM, Simes J, Nowak AK, Cher L, Wheeler H, Hovey EJ, Brown CS, Barnes EH, Sawkins K, Livingstone A, Freilich R, Phal PM, Fitt G; CABARET/COGNO investigators, Rosenthal MA.

Neuro Oncol. 2015 Nov;17(11):1504-13. doi: 10.1093/neuonc/nov104. Epub 2015 Jun 30.

19.

Management of glioblastoma in Victoria, Australia (2006-2008).

Gan HK, Rosenthal MA, Cher L, Dally M, Drummond K, Murphy M, Thursfield V.

J Clin Neurosci. 2015 Sep;22(9):1462-6. doi: 10.1016/j.jocn.2015.03.029.

PMID:
26117358
20.

Ependymoma in adults: Local experience with an uncommon tumour.

Asaid M, Preece PD, Rosenthal MA, Drummond KJ.

J Clin Neurosci. 2015 Sep;22(9):1392-6. doi: 10.1016/j.jocn.2015.03.020. Epub 2015 Jun 18. Review.

PMID:
26094561
21.

Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma.

Behzadigohar R, Rosenthal MA, Tran B.

Can J Urol. 2015 Jun;22(3):7824-6.

PMID:
26068633
22.

Liaison psychiatry in a central nervous system tumor service.

Holmes ACN, Adams SJ, Hall S, Rosenthal MA, Drummond KJ.

Neurooncol Pract. 2015 Jun;2(2):88-92. doi: 10.1093/nop/npv001. Epub 2015 Feb 12.

23.

Hemispheric asymmetry in the formation of musical pitch expectations: a monaural listening and probe tone study.

Rosenthal MA.

Neuropsychologia. 2014 Dec;65:37-40. doi: 10.1016/j.neuropsychologia.2014.10.005. Epub 2014 Oct 16.

PMID:
25447063
24.

Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies.

Field KM, Jordan JT, Wen PY, Rosenthal MA, Reardon DA.

Cancer. 2015 Apr 1;121(7):997-1007. doi: 10.1002/cncr.28935. Epub 2014 Sep 26. Review.

25.

Author reply: To PMID 23279053.

Wong SF, Mak G, Rosenthal MA, Cher L, Gan HK.

Intern Med J. 2014 Feb;44(2):210-1. doi: 10.1111/imj.12338. No abstract available.

PMID:
24528822
26.

Inpatient palliative care consultation for patients with glioblastoma in a tertiary hospital.

Lin E, Rosenthal MA, Eastman P, Le BH.

Intern Med J. 2013 Aug;43(8):942-5. doi: 10.1111/imj.12211.

PMID:
23919337
27.

Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset.

Field KM, Rosenthal MA, Yilmaz M, Tacey M, Drummond K.

Asia Pac J Clin Oncol. 2014 Jun;10(2):153-61. doi: 10.1111/ajco.12076. Epub 2013 May 22.

PMID:
23701649
28.

Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.

Field KM, Drummond KJ, Yilmaz M, Tacey M, Compston D, Gibbs P, Rosenthal MA.

J Clin Neurosci. 2013 Jun;20(6):783-9. doi: 10.1016/j.jocn.2012.09.013. Epub 2013 Apr 29.

PMID:
23639619
29.

Communicating with brain tumor patients about driving: are we falling short of the mark?

Field KM, Guyatt N, Fleet M, Rosenthal MA, Drummond K.

Asia Pac J Clin Oncol. 2014 Mar;10(1):92-3. doi: 10.1111/ajco.12071. Epub 2013 Apr 1. No abstract available.

PMID:
23551566
30.

Spinal cord metastasis in a patient treated with bevacizumab for glioblastoma.

Lomax AJ, Yannakou CK, Rosenthal MA.

Target Oncol. 2013 Jun;8(2):153-5. doi: 10.1007/s11523-013-0270-0. Epub 2013 Feb 21.

PMID:
23430346
31.

Local perspective on a rare brain tumour: adult medulloblastoma.

Wong SF, Mak G, Rosenthal MA, Cher L, Gan HK.

Intern Med J. 2013 May;43(5):567-72. doi: 10.1111/imj.12060. Review.

PMID:
23279053
32.

Neuro-oncology and palliative care: a challenging interface.

Lin E, Rosenthal MA, Le BH, Eastman P.

Neuro Oncol. 2012 Sep;14 Suppl 4:iv3-7. doi: 10.1093/neuonc/nos209. Review. No abstract available.

33.

Redefining the specialist palliative approach: clinical trials, a first year experience.

Le BH, Rosenthal MA.

J Palliat Med. 2012 Aug;15(8):846. doi: 10.1089/jpm.2012.0124. No abstract available.

PMID:
22849596
34.

Glutamate is associated with a higher risk of seizures in patients with gliomas.

Yuen TI, Morokoff AP, Bjorksten A, D'Abaco G, Paradiso L, Finch S, Wong D, Reid CA, Powell KL, Drummond KJ, Rosenthal MA, Kaye AH, O'Brien TJ.

Neurology. 2012 Aug 28;79(9):883-9. doi: 10.1212/WNL.0b013e318266fa89. Epub 2012 Jul 25.

PMID:
22843268
35.

Imaging modalities in high-grade gliomas: pseudoprogression, recurrence, or necrosis?

Caroline I, Rosenthal MA.

J Clin Neurosci. 2012 May;19(5):633-7. doi: 10.1016/j.jocn.2011.10.003. Epub 2012 Feb 8. Review.

PMID:
22321359
36.

Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer.

Mitchell PL, Broad A, Rosenthal MA, Galettis P, Abraham R, Burns I, Clarke S, Milner A, Diiulio J, Links M.

Asia Pac J Clin Oncol. 2011 Dec;7(4):376-84. doi: 10.1111/j.1743-7563.2011.01390.x. Epub 2011 May 23.

PMID:
22151988
37.

Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy.

Ananda S, Nowak AK, Cher L, Dowling A, Brown C, Simes J, Rosenthal MA; Cooperative Trials Group for Neuro-Oncology (COGNO).

J Clin Neurosci. 2011 Nov;18(11):1444-8. doi: 10.1016/j.jocn.2011.02.026. Epub 2011 Aug 2.

PMID:
21813279
38.

An innovative method for determining lipemia interference in blood specimens.

Rosenthal MA, Katz HB.

Clin Chim Acta. 2011 Mar 18;412(7-8):665-7. doi: 10.1016/j.cca.2010.11.025. Epub 2010 Nov 23.

PMID:
21108941
39.

Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.

Corcoran NM, Hovens CM, Michael M, Rosenthal MA, Costello AJ.

Br J Cancer. 2010 Aug 10;103(4):462-8. doi: 10.1038/sj.bjc.6605798. Epub 2010 Jul 20.

40.

Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology.

Field KM, Rosenthal MA, Dimou J, Fleet M, Gibbs P, Drummond K.

J Clin Neurosci. 2010 Sep;17(9):1130-5. doi: 10.1016/j.jocn.2010.03.001. Epub 2010 Jun 8.

PMID:
20570520
41.

Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC.

Pili R, Rosenthal MA, Mainwaring PN, Van Hazel G, Srinivas S, Dreicer R, Goel S, Leach J, Wong S, Clingan P.

Clin Cancer Res. 2010 May 15;16(10):2906-14. doi: 10.1158/1078-0432.CCR-09-3026. Epub 2010 May 11.

42.

A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors.

Gan HK, Rosenthal MA, Dowling A, Kalnins R, Algar E, Wong N, Benson A, Woods AM, Cher L.

Neuro Oncol. 2010 May;12(5):500-7. doi: 10.1093/neuonc/nop065. Epub 2010 Feb 8.

43.

Evaluation of the safety, pharmacokinetics and treatment effects of an alpha(nu)beta(3) integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases.

Rosenthal MA, Davidson P, Rolland F, Campone M, Xue L, Han TH, Mehta A, Berd Y, He W, Lombardi A.

Asia Pac J Clin Oncol. 2010 Mar;6(1):42-8. doi: 10.1111/j.1743-7563.2009.01266.x.

PMID:
20398037
44.

Survival comparison between glioblastoma multiforme and other incurable cancers.

Tran B, Rosenthal MA.

J Clin Neurosci. 2010 Apr;17(4):417-21. doi: 10.1016/j.jocn.2009.09.004. Epub 2010 Feb 18. Review.

PMID:
20167494
45.

A qualitative assessment of the experience of participating in a cancer-related clinical trial.

Wootten AC, Abbott JM, Siddons HM, Rosenthal MA, Costello AJ.

Support Care Cancer. 2011 Jan;19(1):49-55. doi: 10.1007/s00520-009-0787-z. Epub 2009 Dec 4.

PMID:
19960208
46.

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.

Dresemann G, Weller M, Rosenthal MA, Wedding U, Wagner W, Engel E, Heinrich B, Mayer-Steinacker R, Karup-Hansen A, Fluge O, Nowak A, Mehdorn M, Schleyer E, Krex D, Olver IN, Steinbach JP, Hosius C, Sieder C, Sorenson G, Parker R, Nikolova Z.

J Neurooncol. 2010 Feb;96(3):393-402. doi: 10.1007/s11060-009-9976-3. Epub 2009 Aug 18.

PMID:
19688297
47.

Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.

McKeage MJ, Reck M, Jameson MB, Rosenthal MA, Gibbs D, Mainwaring PN, Freitag L, Sullivan R, Von Pawel J.

Lung Cancer. 2009 Aug;65(2):192-7. doi: 10.1016/j.lungcan.2009.03.027. Epub 2009 May 5.

PMID:
19409645
48.

Brain metastases in hormone refractory prostate cancer: a changing natural history?

Roberts-Thomson R, Rosenthal MA, Gonzales M, Drummond K.

Intern Med J. 2009 Mar;39(3):205-6. doi: 10.1111/j.1445-5994.2008.01848.x. No abstract available.

PMID:
19383072
49.

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer.

Pezaro C, Rosenthal MA, Gurney H, Davis ID, Underhill C, Boyer MJ, Kotasek D, Solomon B, Toner GC.

Am J Clin Oncol. 2009 Aug;32(4):338-41. doi: 10.1097/COC.0b013e31818b946b.

PMID:
19363437
50.

Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.

Pavlick AC, Wu J, Roberts J, Rosenthal MA, Hamilton A, Wadler S, Farrell K, Carr M, Fry D, Murgo AJ, Oratz R, Hochster H, Liebes L, Muggia F.

Cancer Chemother Pharmacol. 2009 Sep;64(4):803-10. doi: 10.1007/s00280-009-0931-y. Epub 2009 Feb 17.

Supplemental Content

Loading ...
Support Center